Pulmonary hypertension in COPD is usually mild to moderate in severity, with mPAP between 20 and 35 mmHg with the progression of pulmonary artery pressures at approximately < 0.5 mmHg/year.

Pulmonary hypertension associated with IPF is recognized to have a worse prognosis and poor quality of life.